Department of Neurosciences, Università Cattolica del Sacro Cuore, Rome, Italy.
Dipartimento Scienze dell'Invecchiamento, Neurologiche, Ortopediche e della Testa-Collo, IRCCS Fondazione Policlinico Universitario A. Gemelli, Rome, Italy.
Eur J Neurol. 2021 May;28(5):1590-1600. doi: 10.1111/ene.14749. Epub 2021 Feb 10.
Delirium is a neuropsychiatric disorder of attention and awareness that develops over a short time and fluctuates in severity. Although delirium has been extensively studied in intensive care units, the incidence of delirium in stroke units and its predictors in stroke patients need further investigation. The endpoints of our study were incidence of delirium in acute stroke and the risk factors that predispose to this condition.
Patients were consecutively enrolled in a stroke unit from April to October 2020. Inclusion criteria were: age ≥18 years, acute stroke and National Institute of Health Stroke Scale (NIHSS) score ≥1 at the time of clinical assessment of delirium. Exclusion criteria were: transient ischemic attack; absence of neuroimaging evidence of brain lesion; cerebral venous thrombosis; subarachnoid hemorrhage; and clinical conditions requiring intensive care unit treatment. All patients were evaluated by means of Richmond Agitation-Sedation Scale (RASS) and Confusion Assessment Method-Intensive Care Unit (CAM-ICU) scores at baseline, evaluations which were repeated within 72 h or when patients developed symptoms suggesting delirium.
The overall incidence of delirium was 36/120 (30%). Delirium was associated with aphasia (odds ratio [OR] 9.77; confidence interval [CI] 1.2-79.6), chronic obstructive pulmonary disease (COPD; OR 16.67; CI 1.1-263.0), deep Fazekas score (OR 5.05; CI 1.7-14.8), and physical restraint (OR 45.02; CI 1.4-1411.5). Diabetes was associated with a lower incidence of delirium (OR 0.04; CI 0.026-0.7).
Nearly one-third of patients (30%) had delirium in the acute phase of stroke. This finding supports the notion that delirium is a common complication of stroke. Delirium was associated with speech disorder, leukoencephalopathy, COPD and early use of physical restraint.
谵妄是一种注意力和意识的神经精神障碍,在短时间内发展并严重程度波动。尽管谵妄在重症监护病房中得到了广泛研究,但在卒中病房中谵妄的发生率及其在卒中患者中的预测因素仍需进一步研究。我们研究的终点是急性卒中患者中谵妄的发生率以及导致这种情况的危险因素。
患者连续于 2020 年 4 月至 10 月在卒中病房入组。纳入标准为:年龄≥18 岁,在谵妄的临床评估时 NIHSS 评分≥1。排除标准为:短暂性脑缺血发作;缺乏神经影像学证据的脑损伤;脑静脉血栓形成;蛛网膜下腔出血;以及需要重症监护病房治疗的临床情况。所有患者均通过 Richmond 躁动-镇静量表(RASS)和 ICU 意识模糊评估方法(CAM-ICU)评分进行基线评估,在 72 小时内或当患者出现提示谵妄的症状时重复评估。
总的谵妄发生率为 36/120(30%)。谵妄与失语症(比值比[OR]9.77;置信区间[CI]1.2-79.6)、慢性阻塞性肺疾病(COPD;OR 16.67;CI 1.1-263.0)、深部 Fazekas 评分(OR 5.05;CI 1.7-14.8)和身体约束(OR 45.02;CI 1.4-1411.5)相关。糖尿病与较低的谵妄发生率相关(OR 0.04;CI 0.026-0.7)。
近三分之一(30%)的患者在卒中急性期出现谵妄。这一发现支持谵妄是卒中常见并发症的观点。谵妄与言语障碍、白质脑病、COPD 和早期使用身体约束相关。